Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Starion’s Tissue Welding technology receives Chinese regulatory approval

Starion Instruments : 23 April, 2008  (New Product)
The State Food and Drug Administration (SFDA) of the People's Republic of China has granted regulatory approval for the sale of Starion Instruments’ patented Tissue Welding technology in China.
The Chinese approval marks a significant milestone in Starion’s continued worldwide expansion.

Surgeons in China will now have access to Starion’s full line of advanced surgical devices for sealing and dividing tissue during a broad range of surgical procedures.

Unlike conventional products employing monopolar, bipolar or ultrasonic energy, Starion’s instruments feature the company’s patented Tissue Welding technology, which uses direct heat and pressure to simultaneously seal and divide soft tissue reducing the risk of inadvertent collateral damage.

“Starion’s Tissue Welding technology is unique to the Chinese market and it is changing the way that physicians perform a broad range of minimally invasive and open surgeries,” said Wenjing Ding, MD, Sc.D, president and chief executive officer, Asia Business Service. “Sealing and dividing tissue and blood vessels is a very critical point in any surgery and Starion’s technology is giving surgeons greater confidence to perform this task. Opinion leaders from hospitals across various regions of China enjoyed the convenience and effectiveness of Starion’s instruments in their clinical trials. Based on initial feedback from the clinical community, we are confident that Starion will garner significant market share in the months to come.”

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo